Teva Pharmaceuticals USA, Inc. Recall: Errin (norethindrone tablets, USP), 0.35 mg, 6 blis
Teva Pharmaceuticals USA, Inc. Recall: Errin (norethindrone tablets, USP), 0.35 mg, 6 blis is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA, Inc.; Product: Errin (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen,
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
|---|---|
| Product | Errin (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, Rx Only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0344-58 |
| Reason for recall | Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide and Puerto Rico |
| Recall initiated | 20130315 |
| Recall number | D-689-2013 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →